Crystallographic and docking studies of purine nucleoside phosphorylase from Mycobacterium tuberculosis

Bioorganic & Medicinal Chemistry
2010.0

Abstract

This work describes for the first time the structure of purine nucleoside phosphorylase from Mycobacterium tuberculosis (MtPNP) in complex with sulfate and its natural substrate, 2'-deoxyguanosine, and its application to virtual screening. We report docking studies of a set of molecules against this structure. Application of polynomial empirical scoring function was able to rank docking solutions with good predicting power which opens the possibility to apply this new criterion to analyze docking solutions and screen small-molecule databases for new chemical entities to inhibit MtPNP.

Knowledge Graph

Similar Paper

Crystallographic and docking studies of purine nucleoside phosphorylase from Mycobacterium tuberculosis
Bioorganic & Medicinal Chemistry 2010.0
First Crystal Structures of Mycobacterium tuberculosis 6-Oxopurine Phosphoribosyltransferase: Complexes with GMP and Pyrophosphate and with Acyclic Nucleoside Phosphonates Whose Prodrugs Have Antituberculosis Activity
Journal of Medicinal Chemistry 2015.0
Pharmacophore modeling and structure-based virtual screening for a novel “switch region” target of bacterial RNA polymerase
Medicinal Chemistry Research 2012.0
Molecular Docking Suggests the Targets of Anti-Mycobacterial Natural Products
Molecules 2021.0
Discovery of Novel Nitrobenzothiazole Inhibitors for Mycobacterium tuberculosis ATP Phosphoribosyl Transferase (HisG) through Virtual Screening
Journal of Medicinal Chemistry 2008.0
Structural basis for selective inhibition of purine nucleoside phosphorylase from Schistosoma mansoni: Kinetic and structural studies
Bioorganic & Medicinal Chemistry 2010.0
Discovery of biphenyls bearing thiobarbiturate fragment by structure-based strategy as Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitors
Bioorganic & Medicinal Chemistry 2022.0
Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase
Journal of Medicinal Chemistry 2019.0
Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery
Bioorganic & Medicinal Chemistry 2008.0
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors
Bioorganic & Medicinal Chemistry 2014.0